This track will explore the latest developments in antiretroviral therapies, focusing on novel drug formulations and mechanisms of action. Discussions will include the implications of these advancements for treatment efficacy and patient outcomes.

This session will address the clinical management of HIV, emphasizing evidence-based practices and guidelines. Participants will examine case studies that highlight successful management strategies and patient care models.

This track will investigate factors influencing patient adherence to HIV treatment regimens, including psychological, social, and economic determinants. Strategies to enhance adherence and improve health outcomes will also be discussed.

This session will delve into the pharmacological aspects of HIV medications, including drug interactions and side effects. Emphasis will be placed on optimizing therapeutic regimens for diverse patient populations.

This track will showcase cutting-edge therapeutic innovations in the field of HIV treatment, including long-acting formulations and novel delivery systems. The potential impact of these innovations on patient care will be critically assessed.

This session will provide an overview of ongoing and completed clinical trials in HIV treatment, highlighting key findings and implications for practice. Participants will engage in discussions about the future directions of HIV research.

This track will focus on the role of molecular diagnostics in the management of HIV, including viral load monitoring and resistance testing. Participants will explore how these technologies can inform treatment decisions and improve patient outcomes.

This session will cover advanced laboratory techniques used in HIV research, including novel assays and bioinformatics approaches. The importance of these techniques in understanding HIV pathogenesis and treatment response will be emphasized.

This track will highlight the importance of translational research in bridging the gap between laboratory discoveries and clinical applications in HIV treatment. Case studies will illustrate successful translation of research findings into practice.

This session will examine global disparities in HIV treatment access and outcomes, with a focus on low- and middle-income countries. Participants will discuss strategies to address these challenges and improve global health equity.

This track will explore the psychosocial factors affecting individuals living with HIV, including stigma, mental health, and social support. Strategies to integrate psychosocial care into HIV treatment will be discussed to enhance overall patient well-being.